CHICAGO — An analysis presented here by Eugene J. Carragee, MD, indicates that use of recombinant bone morphogenetic protein-2 in posterior lumbar fusion could be associated with an increase in cancer ...

Please provide your email address to receive an email when new articles are posted on . Recombinant human bone morphogenetic proteins have come a long way since their introduction into the clinical ...

When the U.S. Food and Drug Administration in 2002 approved a product many thought would revolutionize back surgery, the agency did so despite concerns the product might cause serious side effects.

The mechanisms of retinoid activity in tumors remain largely unknown. Here we establish that retinoids cause extensive apoptosis of medulloblastoma cells. In a xenograft model, retinoids largely ...